Johannes Breuning

Questioner
DISC Type : c

Scientific Director at GSK

Cambridge, England, United Kingdom

Overview

Johannes Breuning is a Scientific Director at GSK, where he leads programs developing novel antibody-based cancer therapies. His work focuses on bispecific T-cell engagers and antibody drug conjugates, leveraging his Ph. D. from the University of Oxford and a strong background in T-cell immunology and drug discovery.


During his postdoctoral studies, he won a €30, 000 innovation award for a research project investigating the use of Chimeric Antigen Receptors (CARs) for cancer immunotherapy.

Personality Overview

Systematic

Cautious & Analytical

Value Seeker

They prefer to fully evaluate every situation.  They are more likely than others to negotiate on pricing and terms. While they don't hesitate to ask questions, they are generally risk-averse and tend to be late adopters.

Topics They Care About

Novel Cancer Therapies
His work at GSK is focused on the next generation of cancer treatments, including bispecific T-cell engagers and antibody drug conjugates.
Scientific Leadership
Recently promoted to Scientific Director, he leads a team of scientists, is actively hiring, and manages internal and external scientific collaborations.
T-Cell Immunology
His postdoctoral research and current work on T-cell engagers demonstrate a long-standing expertise in the molecular mechanisms of T-cell activation.

Media Appearances

Johannes has no verified media appearances

Work History

11-2024
Scientific Director at GSK
1-2023 - 11-2024
Associate Director at GSK
10-2021 - 1-2023
Associate Director at GSK
4-2018 - 10-2021
Investigator at GSK
9-2016 - 3-2018
Postdoctoral Researcher at University of Oxford

Education

2012 - 2016
Doctor of Philosophy (PhD) from University of Oxford
2010 - 2011
Master of Science (MSc) from The University of Manchester

More Information

Social Presence :

Prographics :

Exp : 15 Location : Cambridge, England, United Kingdom Job Level : Mid-senior Designation : Scientific Director at GSK
URL has been copied!

Insights For Selling To Johannes

During A Call Or A Meeting

DO's

  • Keep some extra margin in hand as they will likely negotiate the pricing
  • Back up any claims with data and numbers
  • Emphasise more on facts and measurable benefits

DONT's

  • Avoid rushing them, be polite and patient
  • Don’t overhype the product/pitch, keep it measured
  • Don’t depend too much on anecdotal evidence, it reduces their confidence

When Cold Calling

When Writing An Email

While Negotiating & Closing

    The secret to closing fast with Johannes is

  • Confidence that the product provides ROI, effective pricing and process adherence matter the most to them.

  • Will you ever get a clear answer from Johannes

  • It doesn’t come naturally to them but they can say no if they are not convinced.

Insights For Deal Planning

    How fast (or slow) will Johannes move?

  • They can move at a reasonable pace while making their decisions if they have the necessary information.

  • Can Johannes take some risk or not?

  • If they believe that they have analyzed the situation well, they can take a little risk.

You And Johannes

Personality Compatibility


Other GSK Employees

Explore more public profiles from related professionals at the same organization.

More Profiles

Discover additional public profiles from our index.

Search more profiles

Looking for someone else? Search here for anyone.

Or visit Humantic AI to know more.